LENZ Therapeutics Cash Flow Statement (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-54.99M	-20.94M	-27.58M	-636.45M	-34.23M	-28.35M	-17.43M	-49.79M	-53.23M	-18.18M	-16.14M	-10.25M	-10.21M	-12.65M	-15.91M	-14.91M	-16.70M	-35.90M	-42.21M	-31.92M
Depreciation and Depletion (Quarter)	0.20M	0.30M	0.40M	0.60M	0.70M	0.70M	0.70M	0.80M	0.80M	0.10M
Share-based Compensation (Quarter)	2.37M	2.45M	3.34M	3.36M	3.21M	3.62M		2.85M	9.90M		0.95M	0.27M	3.52M	-3.62M	2.56M	-2.56M			4.32M	4.47M
Gains from Investment Securities (Quarter)							0.02M	0.02M	0.11M	-0.27M	1.05M
Asset Writedowns and Impairment (Quarter)									7.21M	13.35M						0.08M			0.41M
Cash from Restructuring (Quarter)											4.82M	-4.77M
Cash from Operations (Quarter)	-15.41M	-15.59M	-21.24M	-22.09M	-22.22M	-22.43M	-12.80M	-13.52M	-13.09M	-20.97M	-23.94M	-15.79M	-10.58M	-9.08M	-16.05M	-11.51M	-8.59M	-33.02M	-33.58M	-38.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)			-0.04M	-0.04M	0.56M	1.12M		0.02M	0.53M	0.51M	0.28M	0.96M	1.36M	1.42M	1.13M	0.89M	0.78M	0.61M	0.32M	0.13M
Depreciation & Amortization (CF) (Quarter)	0.20M	0.33M	0.44M	0.58M	0.65M	0.68M	0.00M	0.00M	0.00M	0.00M	0.01M	0.02M	0.01M	0.03M	0.04M	0.02M	0.12M	0.11M	0.11M	0.11M
Change in Working Capital
Change in Receivables (Quarter)																			0.01M	0.10M
Change in Inventory (Quarter)																		3.33M	0.89M	-0.02M
Change in Account Payables (Quarter)	-2.34M	0.71M	0.58M	0.30M	0.39M	-1.08M	-0.57M	-1.63M	1.97M	1.09M	-1.27M	-2.69M	-1.64M	1.32M	-0.77M	-0.86M	1.69M	-0.16M	6.76M	-4.28M
Change in Accured Expenses (Quarter)	0.94M	1.03M	-1.67M	1.16M	1.17M	0.45M	-0.15M	2.98M	3.34M	1.62M	-7.23M	-2.25M	0.72M	1.30M	-1.20M	2.69M	4.46M	5.03M	-2.11M	-5.11M
Other Working Capital Changes (Quarter)	3.64M	-1.09M	0.07M	-0.60M	2.96M	0.77M	-0.43M	0.35M	-0.41M	-0.28M	0.52M	-0.12M	0.28M	-0.71M	1.00M	0.20M	-0.09M	1.92M	0.34M	2.58M
Investing Activities
Capital Expenditures (Quarter)	3.64M	0.98M	3.27M	1.39M	0.92M	1.02M	0.01M	-0.02M					0.32M	0.15M	0.11M	0.09M	0.58M	-0.79M	-0.00M	0.02M
Sales of Property, Plant and Equipment (Quarter)									0.89M	0.68M
Change in Acquisitions & Divestments (Quarter)					90.00M	80.25M			1.50M	21.00M	18.00M	13.00M	22.00M	34.90M	52.09M	58.12M	52.41M	43.34M	49.23M	45.14M
Cash from Investing Activities (Quarter)	-3.64M	-0.98M	-170.67M	-88.22M	3.50M	13.52M	-0.01M	-26.88M	-17.91M	15.17M	18.00M	-98.39M	-62.23M	-11.86M	18.89M	-0.41M	-4.33M	-89.81M	33.16M	37.75M
Financing Activities
Other financing activities (Quarter)		0.01M			-0.40M	0.64M	0.20M				0.43M	3.41M	-3.84M	4.04M	0.04M	0.20M	-0.01M	0.65M	0.01M	0.38M
Cash from Financing Activities (Quarter)	31.89M	0.31M		0.41M	-0.06M	0.24M	83.18M		-0.57M	-1.91M	171.27M	-2.14M	29.82M	0.05M	0.04M	26.49M	0.60M	122.61M	0.01M	0.40M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)							82.98M	16.98M	-82.98M		53.39M	-3.56M	29.77M	-0.09M		26.10M	0.03M	121.65M
Additional items
Change in Cash (Quarter)	12.84M	-16.26M	-191.91M	-109.90M	-18.78M	-8.66M	70.38M	-40.40M	-31.57M	-7.71M	165.33M	-116.32M	-42.99M	-20.89M	2.88M	14.57M	-12.32M	-0.22M	-0.41M	-0.56M
Free Cash Flow (Quarter)	-19.05M	-16.57M	-24.51M	-23.48M	-23.13M	-23.45M	-12.80M	-13.51M	-13.09M	-20.97M	-23.94M	-15.79M	-10.90M	-9.23M	-16.16M	-11.60M	-9.17M	-32.24M	-33.58M	-38.73M
Net Cash Flow (Quarter)	12.84M	-16.26M	-191.91M	-109.90M	-18.78M	-8.66M	70.38M	-40.40M	-31.57M	-7.71M	165.33M	-116.32M	-42.99M	-20.89M	2.88M	14.57M	-12.32M	-0.22M	-0.41M	-0.56M

Research Tools

Datasets

Plans

Developers

LENZ Therapeutics LENZ Cash Flow Statement (2020-2026)

Research Tools

Datasets

Plans

Developers

LENZ Therapeutics LENZ Cash Flow Statement (2020-2026)

Create an account

Sign In

Reset Password